Trial intelligence / Profile preview

Aspirin and Warfarin in Egyptian Heart Valve Prosthesis Patients

NCT02022527Phase 4Unknown

Sponsor
Pharmacoeconomic Unit
Start
Jun 2013
Primary completion
Jul 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of aspirin in thromboembolism and prosthetic valve thrombosis (PVT) (2 arms), sponsored by Pharmacoeconomic Unit. Primary endpoint: Valve Thrombosis at 1 year. Status: unknown.

02

Drugs

aspirin
03

Conditions

thromboembolismprosthetic valve thrombosis (PVT)

Beyond the preview

Go deeper on NCT02022527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02022527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call